Top Institutions in Neuropsychopharmacology and Psychedelic Neuroscience
Leading institutions in this field typically conduct multi-modal neuroimaging studies combined with advanced computational modeling and Bayesian hierarchical analysis to investigate the acute and long-term effects of psychedelics on brain function and connectivity.
-
#100
Johns Hopkins University
Baltimore, MD
Johns Hopkins is a pioneer in psychedelic research with extensive clinical trials and neuroimaging studies on psilocybin and other psychedelics, contributing foundational knowledge on brain network changes and therapeutic potential.
Key Differentiators
- Neuropsychopharmacology
- Psychedelic Research
- Neuroimaging
-
#92
Imperial College London
London, N/A
Imperial College London has led innovative neuroimaging research on psychedelics, including detailed fMRI studies on LSD and psilocybin, and developed computational models of brain network dynamics under psychedelic influence.
Key Differentiators
- Neuroimaging
- Psychiatry
- Psychedelic Neuroscience
-
#85
University of California, San Francisco (UCSF)
San Francisco, CA
UCSF has a strong focus on clinical and neuroimaging research in neuropsychiatric disorders and psychedelic therapeutics, contributing to understanding the neural mechanisms of psychedelics through multimodal imaging studies.
Key Differentiators
- Psychiatry
- Neuropharmacology
- Neuroimaging
-
#78
Yale University
New Haven, CT
Yale has contributed to psychedelic research with a focus on neurobiological mechanisms and brain network alterations, employing advanced imaging and computational approaches to study psychedelics' effects on brain function.
Key Differentiators
- Psychiatry
- Neuroscience
- Psychedelic Research
-
#75
Massachusetts General Hospital (MGH) / Harvard Medical School
Boston, MA
MGH and Harvard Medical School have extensive expertise in neuroimaging and psychopharmacology, conducting research on psychedelics' impact on brain networks and their potential therapeutic applications.
Key Differentiators
- Psychiatry
- Neuroimaging
- Psychopharmacology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
